Perfusion MDCT of prostate cancer: Correlation of perfusion CT parameters and immunohistochemical markers of angiogenesis

American Journal of Roentgenology

Volumn 199, Issue 5, 2012, Pages 1042-1048

  Osimani, Marcello ^a   Bellini, Davide ^a   Di Cristofano, Claudio ^a   Palleschi, Giovanni ^a   Petrozza, Vincenzo ^a   Carbone, Antonio ^a   Laghi, Andrea ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Angiogenesis; Angiogenesis immunohistochemical markers; Mean vascular area; Mean vascular density; Perfusion CT; Prostate cancer

Indexed keywords

IODINATED CONTRAST MEDIUM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD FLOW; BLOOD VESSEL DIAMETER; BLOOD VOLUME; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; MEAN VASCULAR AREA; MICROVESSEL DENSITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PERFUSION; PERMEABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATISM; RECEIVER OPERATING CHARACTERISTIC;

AGED; BIOPSY; CONTRAST MEDIA; HUMANS; IMMUNOHISTOCHEMISTRY; IOHEXOL; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84868007800     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.8267     Document Type: Article

References (42)

1. Kai L, Wang J, Ivanovic M, et al. Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1). Prostate 2011;71:268-280
2. Aragon-Ching JB, Dahut WL. VEGF inhibitors and prostate cancer therapy. Curr Mol Pharmacol 2009;2:161-168
3. Kluetz PG, Figg WD, Dahut WL. Angiogenesis inhibitors in the treatment of prostate cancer. Expert Opin Pharmacother 2010;11:233-247
4. Bunsiripaiboon P, Sornmayura P, Wilasrusmee C, et al. The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma. J Med Assoc Thai 2010;93:66-72
5. Erbersdobler A, Isbarn H, Dix K, et al. Prognostic value of microvessel density in prostate cancer: a tissue microarray study. World J Urol 2010;28:687-692
6. Cuenod CA, Fournier L, Balvay D, et al. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 2006;31:188-193
7. Padhani AR, Harvey CJ, Cosgrove DO. Angiogenesis imaging in the management of prostate cancer. Nat Clin Pract Urol 2005;2:596-607 (Pubitemid 43135243)
8. Chen TW, Yang ZG, Wang QL, et al. Whole tumour quantitative measurement of first-pass perfusion of oesophageal squamous cell carcinoma using 64-row multidetector computed tomography: correlation with microvessel density. Eur J Radiol 2011;79:218-223
9. Jiang NC, Han P, Zhou CK, Zheng JL, Shi HS, Xiao J. Dynamic enhancement patterns of solitary pulmonary nodules at multi-detector row CT and correlation with vascular endothelial growth factor and microvessel density. Ai Zheng 2009;28:164-169
10. Feng ST, Sun CH, Li ZP, et al. Evaluation of angiogenesis in colorectal carcinoma with multidetectorrow CT multislice perfusion imaging. Eur J Radiol 2009;75:191-196
11. Faggioni L, Neri E, Bartolozzi C. CT perfusion of head and neck tumors: how we do it. AJR 2010;194:62-69
12. Ng CS, Wang X, Faria SC, Lin E, Charnsangavej C, Tannir NM. Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon. AJR 2010;194:166-171
13. Yang HF, Du Y, Ni JX, et al. Perfusion computed tomography evaluation of angiogenesis in liver cancer. Eur Radiol 2010;20:1424-1430
14. Henderson E, Milosevic MF, Haider MA, et al. Functional CT imaging of prostate cancer. Phys Med Biol 2003;48:3085-3100 (Pubitemid 37192922)
15. Win Z, Ariff B, Harvey CJ, et al. Comparative study of experienced vs non-experienced radiologists in assessing parametric CT images of the response of the prostate gland to radiotherapy. Br J Radiol 2008;81:572-576 (Pubitemid 351958449)
16. Ives EP, Burke MA, Edmonds PR, et al. Quantitative computed tomography perfusion of prostate cancer: correlation with whole-mount pathology. Clin Prostate Cancer 2005;4:109-112 (Pubitemid 41474605)
17. Tawfik AM, Nour-Eldin NE, Naguib NN, et al. CT perfusion measurements of head and neck carcinoma from single section with largest tumor dimensions or average of multiple sections: agreement between the two methods and effect on intra-and inter-observer agreement. Eur J Radiol 2011 Dec. 7 [Epub ahead of print]
18. Korporaal JG, Van Den Berg CA, Jeukens CR, et al. Dynamic contrast-enhanced CT for prostate cancer: relationship between image noise, voxel size, and repeatability. Radiology 2010;256:976-984
19. Purdie TG, Henderson E, Lee TY. Functional CT imaging of angiogenesis in rabbit VX2 soft tissue. Phys Med Biol 2001;46:3161-3175 (Pubitemid 34568065)
20. St. Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain. I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365-1377 (Pubitemid 28559684)
21. Beliën JA, Somi S, De Jong JS, Van Diest PJ, Baak JP. Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol 1999;52:184-192 (Pubitemid 29125410)
22. Dorn F, Muenzel D, Meier R, Poppert H, Rummeny EJ, Huber A. Brain perfusion CT for acute stroke using a 256-slice CT: improvement of diagnostic information by large volume coverage. Eur Radiol 2011;21:1803-1810
23. Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 2007;63:335-350 (Pubitemid 47321040)
24. Scherr MK, Seitz M, Muller-Lisse UG, et al. MRperfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and modelbased gadobenate dimeglumine MRP parameters in detection of prostate cancer. Eur J Radiol 2010;76:359-366
25. Franiel T, Hamm B, Hricak H. Dynamic contrastenhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol 2011;21:616-626
26. Oto A, Kayhan A, Jiang Y, et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusionweighted and dynamic contrast-enhanced MR imaging. Radiology 2010;257:715-723
27. Franiel T, Lüdemann L, Rudolph B, et al. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversionprepared dual-contrast gradient echo sequence. Invest Radiol 2008;43:481-487
28. Carreira GC, Gemeinhardt O, Gorenflo R, et al. Limitations of the permeability-limited compartment model in estimating vascular permeability and interstitial volume fraction in DCE-MRI. Magn Reson Imaging 2011;29:639-649
29. Ungersma SE, Pacheco G, Ho C, et al. Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magn Reson Med 2011;65:889-899
30. Bellomi M, Viotti S, Preda L, D'Andrea G, Bonello L, Petralia G. Perfusion CT in solid body-tumours. Part II. Clinical applications and future development. Radiol Med 2010;115:858-874
31. Goh V, Halligan S, Taylor SA, et al. Differentiation between diverticulitis and colorectal cancer: quantitative CT perfusion measurements versus morphologic criteria-initial experience. Radiology 2007;242:456-462 (Pubitemid 46150970)
32. Goh V, Halligan S, Daley F, et al. Colorectal tumor vascularity: quantitative assessment with multidetector CT-do tumor perfusion measurements reflect angiogenesis? Radiology 2008;249:510-517
33. Kan Z, Phongkitkarun S, Koyabashi S, et al. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. Radiology 2005;237:151-158 (Pubitemid 41346159)
34. Gabra P, Shen G, Xuan J, Lee TY. Arterio-venous anastomoses in mice affect perfusion measurements with dynamic contrast enhanced CT. Physiol Meas 2010;31:249-260
35. Oyen RH. Dynamic contrast-enhanced MRI of the prostate: is this the way to proceed for characterization of prostatic carcinoma? Eur Radiol 2003;13:921-924 (Pubitemid 36790582)
36. Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986;31:288-305 (Pubitemid 16076428)
37. Jain RK. Transport of molecules across tumor vasculator. Cancer Metastasis Rev 1987;6:559-593
38. Harvey CJ, Blomley MJ, Dawson P, et al. Functional CT imaging of the acute hyperemic response to radiation therapy of the prostate gland: early experience. J Comput Assist Tomogr 2001;25:43-49 (Pubitemid 32099207)
39. Schmuecking M, Boltze C, Geyer H, et al. Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer? Int J Radiat Biol 2009;85:814-824
40. Sung YS, Kwon HJ, Park BW, et al. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps. AJR 2011;197:1122-1129
41. Beyersdorff D, Lüdemann L, Dietz E, Galler D, Marchot P, Franiel T. Dynamic contrast-enhanced MRI of the prostate: comparison of two different post-processing algorithms [in German]. Rofo 2011;183:456-461
42. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-577 (Pubitemid 23118304)